Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Treasury Shares: 2021-2025

Historic Treasury Shares for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to $3.5 million.

  • Prime Medicine's Treasury Shares changed negligibly% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $3.5 million for FY2024, which is 9.40% down from last year.
  • Per Prime Medicine's latest filing, its Treasury Shares stood at $3.5 million for Q3 2025, which was down 0.00% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Treasury Shares ranged from a high of $10.8 million in Q4 2021 and a low of $3,116 during Q2 2022.
  • In the last 3 years, Prime Medicine's Treasury Shares had a median value of $3.5 million in 2025 and averaged $3.6 million.
  • In the last 5 years, Prime Medicine's Treasury Shares slumped by 55.87% in 2022 and then spiked by 122,902.86% in 2023.
  • Quarterly analysis of 5 years shows Prime Medicine's Treasury Shares stood at $10.8 million in 2021, then crashed by 53.57% to $5.0 million in 2022, then dropped by 23.57% to $3.8 million in 2023, then decreased by 9.40% to $3.5 million in 2024, then climbed by 0.00% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $3.5 million for Q2 2025, and $3.5 million during Q1 2025.